DIALYSIS · CCN 452840

USRC HOUSTON HOME THERAPIES

HOUSTON, TX 77054

DialysisProfitUS Renal Care, Inc.
$2.8M
TOTAL REVENUE
-3.9%
OPERATING MARGIN
3 / 5
STAR RATING
13
QUALITY MEASURES
US Renal Care, Inc.
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$2.8M
Total costs
$3.0M
Operating income (rev − costs)
−$111K
Operating margin
-3.9%
Total charges
$2.8M
Total treatments
5,725
Dialysis stations
—

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Percent of Adult HD Patients with Kt/V >= 1.2
DFC_ADULT_HD_KTV
9518—
Percentage of Adult PD Patients with Kt/V >= 1.7
DFC_ADULT_PD_KTV
9126—
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.4719—
Fistula Rate
DFC_FISTULA_RATE
57.928—
Five Star Rating
DFC_FIVE_STAR
3——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
0.9145—
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
151.738—
Percentage of Adult Patients with Hypercalcemia
DFC_HYPERCALCEMIA
054—
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
2328—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
22.4182—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
28.453—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
16.922—
Standardized ED Visits Ratio
DFC_SEDR
0.3516—